SALADINI, GIORGIO
SALADINI, GIORGIO
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis.
2013 Evangelista, Laura; Zattoni, Fabio; Guttilla, Andrea; Saladini, Giorgio; Zattoni, Filiberto; Colletti Patrick, M.; Rubello, Domenico
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [18F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis
2015 Evangelista, Laura; Cimitan, Marino; Zattoni, Fabio; Guttilla, Andrea; Zattoni, Filiberto; Saladini, Giorgio
Correlation between cancer antigen 15.3 value and qualitative and semiquantitative parameters of positron emission tomography/computed tomography in breast cancer patients
2014 Cervino, Ar; Saibene, T; Michieletto, S; Ghiotto, C; Bozza, F; Saladini, G; Evangelista, L
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients
2017 Evangelista, Laura; Cervino, Anna R.; Michieletto, Silvia; Saibene, Tania; Ghiotto, Cristina; Guarneri, Valentina; Conte, Pierfranco; Reccia, Pasquale; Saladini, Giorgio
Other than restaging phase: serial FCH-PET/CT scans can predict the reponse to chemotherapy (CT) in castrate-resistant prostate cancer (CRPCa)?
2015 Evangelista, Laura; Basso, Umberto; Guttilla, Andrea; Zattoni, Fabio; Cervino, Anna; Zattoni, Filiberto; Zagonel, Vittorina; Saladini, Giorgio
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
2016 Alongi, Pierpaolo; Picchio, Maria; Zattoni, Fabio; Spallino, Marianna; Gianolli, Luigi; Saladini, Giorgio; Evangelista, Laura
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT
2017 Cuppari, L.; Lombardi, G.; Evangelista, L.; Pambuku, A.; Saladini, G.; Zagonel, V.